Podcasts about nyu grossman school

I'm delighted to connect with Dr. Rachel Goldman today. She is a licensed clinical psychologist based in New York City and a clinical assistant professor in the Department of Psychiatry at NYU Grossman School of Medicine. She specializes in the mind-body connection using cognitive behavioral therapy, with a focus on stress management, burnout, distorted eating, bariatric surgery support, and health behavior changes. I was honored to meet Dr. Rachel in Miami at an event where we both spoke earlier this year. In our conversation, we discuss how to approach body image in midlife, how our families influence our relationships with food, what toxic positivity is, and how it invalidates our emotions. We also explore the vulnerability of midlife and parenting, the effects of GLP-1 drugs, obesity as a disease, and the impact of mindset. Dr. Rachel also defines burnout and shares the best ways to address it. Stay tuned for today's invaluable conversation on body image, mindset, emotions, and navigating the challenges of midlife. IN THIS EPISODE, YOU WILL LEARN: Dr. Rachel shares her approach to helping midlife women struggling with body image and identity  How our thought processes around food can influence our emotions and behaviors Various factors that can influence our relationship with food How women with many rules around food can start changing their thinking How to navigate grief about your younger body and learn to appreciate the body you have now What toxic positivity is and how it invalidates our emotions How personal and professional role changes in midlife can affect a woman's sense of identity Why Dr. Rachel recommends having more than one coping tool in your toolbox  The effects Dr. Rachel has been seeing in patients using GLP-1 medications What burnout is, and how to address it Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Connect with Dr. Rachel Goldman On social media: @DrRachelNYC   Purchase links for Dr. Rachel's book are available HERE.

Dr. Kellie Owens, is an assistant professor in the section of medical ethics at NYU Grossman School of Medicine. She's a sociologist and empirical bioethicist studying how digital technologies are woven into the fabric of healthcare and society and how governance structures can better support those affected by technological change. She also leads the responsible AI review process for the Division of Applied AI Technologies and with the IRB. PART 2 In medicine, we do know that examples of bias and harm from that bias have happened. The most famous case was brought to our attention from Ziad Obermeyer and his colleagues in Science in 2019. It was examining racial discrimination resulting from a commercial algorithm that was widely used by health systems to identify patients with complex health needs that might need extra support. Instead, we found that the algorithm was prioritizing white patients over black patients and was reducing the number of black patients who should have been enrolled in those care management programs by more than half. In some ways, there are pretty easy ways to fix these kinds of biases and problems if we're attuned to them. So once we see them, we can usually fix them. In this case, training the model using active chronic conditions rather than total costs would have significantly reduced bias.  The point is that understanding the social context in which an algorithm is developed and is operating in is really important. Otherwise, it can be pretty easy to make mistakes like this if you're not paying attention to disparate impacts in the ways that our choices in algorithm development can have impacts on fairness and outcomes for different groups. Another major ethics consideration touched upon in her presentation is mostly about data privacy.

Dr. Rachel Goldman is a clinical psychologist and Clinical Assistant Professor of Psychiatry at NYU Grossman School of Medicine who spent years as a bariatric psychologist and is a leading expert in the psychology of weight, food, and behavior change. In this conversation, she explains why losing weight rarely delivers the happiness people expect, the mindset foundations that make change actually stick, and how to build a healthier relationship with food, GLP-1s, and the data we track about ourselves.In this episode, we discuss:(0:00) Trailer(03:47) The Biggest Myth About How Weight Loss Will Make You Feel(05:04) Why 80–95% Regain Weight: Obesity As A Recurring Disease(09:49) Why Quick-Fix Overhauls Fail And Baby Steps Win(11:54) The Mental Foundations To Build Before Losing Weight(14:55) What Makes A Good "Why" For Losing Weight(16:26) The Non-Scale Victories That Matter Most(21:27) The Truth Behind Post-Surgery Self-Harm Headlines(25:52) How To Build A Healthier Relationship With Food(27:42) Addiction Transfer: Why You Swap One Habit For Another(30:15) The Cookie Strategy: Why You Should Just Eat It(32:32) How Your Self-Talk Becomes Your Reality(35:19) Who GLP-1s Like Ozempic Are Actually For(41:23) "Ozempic Personality" And Anhedonia Explained(45:53) Over-Optimization: Wearables, Orthorexia, And Orthosomnia(58:16) Why Human Connection Beats Your Sleep ScoreLearn more about Dr. Goldman here:Website: https://www.drrachelnyc.comInstagram: https://www.instagram.com/drrachelnycBook (When Life Happens): https://whenlifehappensbook.comWatch this episode on Youtube:https://youtu.be/owZKpO0Drvs

A man who was convicted of manslaughter for killing his father in 2010 was arrested on suspicion of first-degree arson in connection to the largest of the three fires burning near Spokane, Washington. Firefighters say hundreds of structures have been destroyed so far. Kris Van Cleave has more.A drone hit a packed beach in southern Russia on Monday on the Black Sea coast. Russian officials say seven people were killed and dozens were injured. Holly Williams reports.The Michigan Department of Health confirms two people have died after contracting cyclosporiasis. The department said both individuals "had significant underlying health conditions that may have been impacted by cyclosporiasis and dehydration." Carter Evans reports.Last month, a 16-year-old lifeguard rescued 10-year-old Nathaniel Rai, who was struggling in a rip current off Santa Cruz, California. Rai and his father spoke to "CBS Mornings" about how the terrifying situation unfolded and their gratitude for the teen lifeguard who stepped in to help.One day after announcing she'll step back from the spotlight after her tour ends, Ariana Grande spoke directly to fans at Monday night's show in Chicago. The singer said the decision was her own and "was made from a thoughtful and empowered place."Dr. Elizabeth Hale, a clinical associate professor of dermatology at NYU Grossman School of Medicine, speaks to "CBS Mornings" about summer skincare routines, if there are any products to avoid and ways to prevent sunburn.A new report from Zelle found 76% of Gen Z have fronted money for a group expense and were never fully repaid. Elaine Swann, an etiquette expert, shares how to have money conversations with friends if you're splitting expenses.Tony Award-winning producer Jordan Roth talks about starring in the "The Shards" and describes what it was like to go from behind the scenes on Broadway to making his major on-screen acting debut.

Last month, a 16-year-old lifeguard rescued 10-year-old Nathaniel Rai, who was struggling in a rip current off Santa Cruz, California. Rai and his father spoke to "CBS Mornings" about how the terrifying situation unfolded and their gratitude for the teen lifeguard who stepped in to help. Dr. Elizabeth Hale, a clinical associate professor of dermatology at NYU Grossman School of Medicine, speaks to "CBS Mornings" about summer skincare routines, if there are any products to avoid and ways to prevent sunburn. A new report from Zelle found 76% of Gen Z have fronted money for a group expense and were never fully repaid. Elaine Swann, an etiquette expert, shares how to have money conversations with friends if you're splitting expenses Tony Award-winning producer Jordan Roth talks about starring in the "The Shards" and describes what it was like to go from behind the scenes on Broadway to making his major on-screen acting debut.

New imaging and measurement approaches are revealing previously hidden aspects of microbial life, challenging long-held assumptions and creating opportunities to answer questions that were once out of reach. Marvin Whiteley, Heran Darwin and Jeffrey Moffitt talk about how technological innovation is transforming microbiology. Guests: Heran Darwin, Ph.D. - NYU Grossman School of Medicine Jeffrey Moffitt, Ph.D. - Boston Children's Research This episode of Editors in Conversation is brought to you by mBio® and hosted by mBio Editor in Chief, Marvin Whiteley, Ph.D.  Visit journals.asm.org/journal/mbio to read articles and/or submit a manuscript. Receive up to 50% off fees when you publish in mBio® or any of the ASM journals by becoming an ASM member. Sign up at asm.org/joinasm.

Dr. Kellie Owens, is an assistant professor in the section of medical ethics at NYU Grossman School of Medicine. She's a sociologist and empirical bioethicist studying how digital technologies are woven into the fabric of healthcare and society and how governance structures can better support those affected by technological change. She also leads the responsible AI review process for the Division of Applied AI Technologies and with the IRB. Part 1 Dr. Owens began by indicating that by AI, she means any computer system that's designed to perform tasks that typically require human intelligence, which could be things like recognizing patterns, interpreting data, making predictions, or even making decisions. In the health care context, that means AI systems that analyze complex. medical data that assist with diagnosis or risk prediction that can help automate some routine processes.  She wants to talk mostly about the less fun side, the sort of limitations and potential harms that we have to be aware of to make sure that we're using this technology responsibly. Her focus today is on the people and process side of AI integration and not the technical side. Examples raised today focus specifically on health care implementation. She indicated that there are increasing calls from AI developers and users and regulators and folks in ethics to increase evidence standards for implementing new AI systems. The majority fall outside of FDA regulation, which means they really haven't undergone any formal review for safety and efficacy. The stated goals of ambient documentation, ambient scribes, are to give doctors more time with their patients or more time with their families. We are going to have to vigorously defend that time savings. Otherwise, that free time will be used in plenty of ways that don't touch the problem of physician burnout at all. She wants to be really intentional about how we think about time savings and efficiency regarding AI.

In this episode, we speak with Andrea Brand, Chair of the Department of Cell Biology at NYU Grossman School of Medicine and Director of the Regenerative Medicine Institute. We discuss her scientific path from yeast gene regulation to Drosophila neurobiology, and how early interests in DNA and microscopy shaped her career. We talk about the development of the GAL4 system with Norbert Perrimon and how it enabled targeted gene expression in specific tissues and cells. Andrea explains why this approach has remained useful across decades, including its applications in Drosophila and beyond, while noting that no experimental system is perfect and results should be cross-checked with other methods. We also discuss targeted DAM-ID and chromatin DAM-ID, methods developed in her lab to study protein-DNA interactions and chromatin marks in vivo without removing cells from their normal tissue environment. Andrea describes how these tools helped her lab analyze neural stem cells in their niche and investigate changes in chromatin during quiescence and reactivation. A major theme of the conversation is neural stem cell quiescence. We cover how her lab found that quiescent stem cells can show unexpectedly open chromatin, express neuronal genes, and adopt neuron-like features, including long projections and interactions with neurons. We also discuss the link to metabolism, including feeding signals, the fat body, blood-brain barrier glia, insulin-like peptides, and TGF-beta signaling. Finally, we talk about Andrea's recent move toward human brain organoids and the goal of connecting model organism work to human biology and patient data. We discuss ongoing work on quiescent cells, TRIB family genes, and cancer–neuron interactions, as well as the need to better distinguish quiescence from senescence in vivo. References Brand, A. H., & Perrimon, N. (1993). Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development (Cambridge, England), 118(2), 401–415. https://doi.org/10.1242/dev.118.2.401 Southall, T. D., Gold, K. S., Egger, B., Davidson, C. M., Caygill, E. E., Marshall, O. J., & Brand, A. H. (2013). Cell-type-specific profiling of gene expression and chromatin binding without cell isolation: assaying RNA Pol II occupancy in neural stem cells. Developmental cell, 26(1), 101–112. https://doi.org/10.1016/j.devcel.2013.05.020 Tang, J. L. Y., Hakes, A. E., Krautz, R., Suzuki, T., Contreras, E. G., Fox, P. M., & Brand, A. H. (2022). NanoDam identifies Homeobrain (ARX) and Scarecrow (NKX2.1) as conserved temporal factors in the Drosophila central brain and visual system. Developmental cell, 57(9), 1193–1207.e7. https://doi.org/10.1016/j.devcel.2022.04.008 Cheetham, S. W., & Brand, A. H. (2018). RNA-DamID reveals cell-type-specific binding of roX RNAs at chromatin-entry sites. Nature structural & molecular biology, 25(1), 109–114. https://doi.org/10.1038/s41594-017-0006-4 Cheetham, S. W., Gruhn, W. H., van den Ameele, J., Krautz, R., Southall, T. D., Kobayashi, T., Surani, M. A., & Brand, A. H. (2018). Targeted DamID reveals differential binding of mammalian pluripotency factors. Development (Cambridge, England), 145(20), dev170209. https://doi.org/10.1242/dev.170209 Related Episodes scDamID, EpiDamID and Lamina Associated Domains (Jop Kind) Characterizing Chromatin at the Nuclear Lamina (Bas van Steensel) Contact Epigenetics Podcast on Mastodon Epigenetics Podcast on Bluesky Dr. Stefan Dillinger on LinkedIn Active Motif on LinkedIn Active Motif on Bluesky Email: podcast@activemotif.com

In this episode, host Jasmine Heidary sits down with Dr. Jonathan Silver, an internationally recognized leader in neuropsychiatry and a pioneer in the study and treatment of traumatic brain injury (TBI). A clinical professor of psychiatry at NYU Grossman School of Medicine, Dr. Silver has spent decades advancing our understanding of how brain injury affects behavior and mental health — shaping clinical programs at Columbia University, Lenox Hill Hospital, and NYU, and contributing to foundational textbooks and national treatment guidelines in the field.Fresh off receiving the 2026 Gary J. Tucker, MD Lifetime Achievement Award from the American Neuropsychiatric Association, Dr. Silver joins us to explore the evolving field of neuropsychiatry, his path into the specialty, and what decades of work at the intersection of neurology and psychiatry have taught him about the brain, behavior, and healing.*Clarification at 25:36: Mild traumatic brain injury is characterized by amnesia lasting less than 24 hours and loss of consciousness lasting less than 30 minutes.---Music from #Uppbeat (free for Creators!):https://uppbeat.io/t/torus/layers-of-lifeLicense code: 4BPPLFF6KL9N7G4Q

In today's episode, we spoke with Joshua K. Sabari, MD. Dr Sabari is an assistant professor in the Department of Medicine at NYU Grossman School of Medicine, and director of High Reliability Organization Initiatives at NYU Langone Health's Perlmutter Cancer Center New York. In our exclusive interview, Dr Sabari discussed the complexities of managing small cell lung cancer (SCLC) across both academic and community settings, emphasizing that nothing about this disease is straightforward. He stressed the importance of rapid diagnosis and staging, ideally within 48 to 72 hours given how quickly patients can deteriorate, and noted that in his own academic practice, approximately 30% of patients never reach second-line therapy, a figure that climbs to 50% to 60% in the community setting.He highlighted 2 areas where community implementation frequently breaks down: first-line maintenance and second-line therapy. Regarding maintenance, Dr Sabari underscored the need to counsel patients about the combination of atezolizumab (Tecentriq) plus lurbinectedin (Zepzelca) from the outset of treatment, so the transition after 4 cycles of chemoimmunotherapy is not a surprise. In the second-line setting, he addressed the practical challenges of administering tarlatamab-dlle (Imdelltra), a CD3 x DLL3 bispecific T-cell engager, noting that the first 2 doses require inpatient monitoring given the risks of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS). However, he noted that these monitoring resources may not be readily available outside of academic centers.The discussion also covered the evolving role of the multidisciplinary care team, with Dr Sabari highlighting the outsized impact of dedicated thoracic pharmacists in educating patients, monitoring for adverse effects (AEs), and intervening early, particularly with novel agents whose AE profiles are still being characterized. He shared real-world examples of coordination saves, including a radiologist who flagged early pneumonitis and a patient receiving tarlatamab who developed subtle cognitive changes that were initially missed.Finally, Dr Sabari outlined the top educational gaps for community teams: understanding the biological heterogeneity of SCLC, recognizing when and how to use emerging agents such as tarlatamab and obrixtamig (BI 764532), and developing fluency in managing novel toxicities including CRS, ICANs, and interstitial lung disease associated with antibody-drug conjugates.

In this episode of SurgOnc Today, Dr. Patricio Polanco from Atrium Health Wake Forest University School of Medicine and Dr. Rebecca Snyder from MD Anderson Cancer Center, Chair and Vice-Chair of the HPB Disease Site Working Group, are joined by Dr. Caitlin Hester from University of Miami and Dr. Greg Sacks from NYU Grossman School of Medicine. On today's episode, we will be discussing some of the most exciting research and topics discussed at this year's AHPBA 2026 annual meeting in Miami, Florida. Abstracts: https://www.sciencedirect.com/journal/hpb/vol/28/suppl/S1

Augustin Guibaud, PhD, fire expert in the NYU Tandon School of Engineering Department of Mechanical and Aerospace Engineering, explains why Canada's forest fires present a unique challenge for experts and first responders—and how forest management can help prevent them in a world marked by climate change. Then, Rebecca Florsheim, MD, MPH, environmental health physician at the NYU Grossman School of Medicine, discusses the health impacts of wildfire smoke and poor air pollution. Photo: NEW YORK CITY, UNITED STATES - JULY 16: Smoke from massive wildfires in Canada engulfed the New York City skyline, reducing visibility and casting an orange haze over the New York City, United States on July 16, 2026. The smoky conditions reduced visibility across the skyline, while authorities continued monitoring air quality as the wildfire smoke spread across the northeastern United States. (Photo by Selcuk Acar/Anadolu via Getty Images)   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

About this episode:   Individuals awaiting organ transplants are often encouraged to reach out to family, friends, neighbors, and colleagues to ask if they will consider becoming a living organ donor. As social media expands our reach beyond our immediate communities, it could become a powerful tool in connecting recipients with donors. In this episode: Macey Levan, a kidney donor and researcher, explains why social media can be so useful in forging life-saving connections and what to consider when making the ask of an online community.  Guest:  Macey Levan, PhD, JD, is an associate professor of surgery and population health at NYU Grossman School of Medicine. She also serves as director of policy and external affairs for the Transplant Institute and director of the qualitative core in the Center for Surgical and Transplant Applied Research.  Host:  Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs.  Show links and related content:  Social Media in the Identification of Living Kidney Donors: Platforms, Tools, and Strategies—Current Transplantation Reports  Social media and organ donation: Ethically navigating the next frontier—American Journal of Transplantation  Kidney Donation: How to Make the Ask—National Kidney Foundation  Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Host: Steve Jackson, PharmD Guest: Souptik Barua, PhD Guest: Emily Johnston, MPH, PhD Can older adults successfully engage with telehealth, wearable technology, and digital health tools to prevent type 2 diabetes? In this conversation with Dr. Steve Jackson, Ds. Emily Johnston and Dr. Souptik Barua discuss emerging insights on how these strategies could improve accessibility and engagement in a high-risk population. Dr. Johnston is a Research Assistant Professor in the Department of Medicine, and Dr. Barua is an Assistant Professor in the Division of Precision Medicine at the NYU Grossman School of Medicine. They presented these findings at the 2026 American Diabetes Association Scientific Sessions.

The following question refers to Section 7.1 of the 2025 ACS Guidelines. The question is asked by Thomas Jefferson medical student and CardioNerds Academy Intern Dr. Grace Qiu, answered first by University of Michigan fellow and CardioNerds FIT Ambassador Dr. Kayla Secrest, and then by expert faculty Dr. Sunil Rao. Dr. Rao is an interventional cardiologist, Professor of Medicine at NYU Grossman School of Medicine, Deputy Director of the Leon H. Charney Division of Cardiology, and the Director of Interventional Cardiology for the NYU Langone Health System. He is the Editor-in-Chief for Circulation Cardiovascular Interventions and was the Chair of the Writing Committee for the 2025 ACS Guidelines. This episode is part of our comprehensive Decipher the Guidelines Series covering the 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Question #1 A 68-year-old man with a history of hypertension, hyperlipidemia, stage III chronic kidney disease, and prior tobacco use presents to a local emergency department with reports of chest pain while raking leaves at home. Upon arrival, he is hemodynamically stable with a heart rate of 86 beats per minute and a blood pressure of 133/85 mmHg. His EKG reveals ST elevations in the septal and anterior leads (V1-V4). He is given 324mg of aspirin and is promptly evaluated by the interventional cardiology team, who elects to take him emergently to the catheterization lab. Upon arrival to the catheterization lab, the nurse asks the interventional fellow which access sites they should prep for this case? How should the interventional fellow respond? A Right radial artery only B Radial + bilateral femoral C Bilateral femoral only Answer #1 Explanation  The correct answer is B. Radial and bilateral femoral Radial artery access is the preferred vascular access site for coronary angiography and PCI in patients with ACS. Transradial access has been shown to reduce mortality, bleeding, and vascular complications compared with transfemoral access (Class I, LOE A). Radial access also allows earlier ambulation and is associated with greater patient comfort. Although the right radial artery is the most widely studied upper-extremity access site, alternative sites such as the ulnar and distal radial arteries have demonstrated similar outcomes. However, the radial artery may be required as a bypass conduit for CABG. In institutions where the radial artery is routinely used for surgical grafting, this potential future use should be considered when selecting vascular access. In addition, transfemoral access—preferably performed with ultrasound guidance—should be considered in patients in whom temporary mechanical circulatory support (MCS) is anticipated or in those for whom radial access is not feasible due to anatomical or technical constraints. Prepping bilateral groins in addition to the radial artery provides a backup strategy for urgent MCS placement or for transition to femoral access should radial access fail. For these reasons, prepping both the radial artery and bilateral groins is the most appropriate response. Radial-only preparation is incorrect because, although radial access is preferred, patients with STEMI may still require emergent MCS or alternative access if the radial artery is unsuitable. Preparing only the wrist without backup femoral access may delay care should hemodynamic instability occur. Femoral-only preparation is incorrect because transradial access provides superior outcomes in ACS, including significant reductions in all-cause mortality, major bleeding, and vascular complications. RCTs and meta-analyses, including MATRIX (which showed lower MACE and net adverse clinical events with radial access) and SAFARI-STEMI (which showed no difference in mortality but was underpowered)—support radial as first-line access when feasible. Main Takeaway For patients with ACS undergoing PCI, radial access is strongly preferred to reduce mortality, bleeding, and vascular complications. Guideline Loc. Section 7.1  

What does it take to build a culture of ethics inside a health system — and what happens when leaders lack the courage to defend it? In this episode of SoundPractice, host Mike Sacopulos sits down with Arthur Caplan, PhD, one of the world's foremost bioethicists and the founding head of the Division of Medical Ethics at NYU Grossman School of Medicine's Department of Population Health. Dr. Caplan traces his path into bioethics from a childhood hospitalization for polio to graduate training at Columbia, where he witnessed firsthand the ethical gaps in medicine's early encounters with IVF, informed consent, and research oversight. That experience shaped a career devoted not just to theorizing about ethics, but to solving real problems in real institutions. In this wide-ranging conversation, Dr. Caplan and Mike Sacopulos explore: - What an effective ethics infrastructure looks like - The defining bioethical challenges of the next decade - Compassionate use and unproven therapies - Misinformation and informed consent - Rationing and equity - Bioethics training for the next generation Learn more about the American Association for Physician Leadership.

Neil Theise (thee-ss) is adjunct professor of pathology at the NYU Grossman School of Medicine. Through his scientific research, he has been a pioneer of adult stem cell plasticity and the anatomy of the human interstitium.  Dr. Theise's book, "Notes on Complexity: A Scientific Theory of Connection, Consciousness, and Being" calls on his studies in complexity theory to address topics such as consciousness studies and science-religion dialogue.  Recently his scientific understandings of integrative medicine have been highlighted in the New York Times, on The Telepathy Tapes, and soon in the documentary, "Phenomena Healing."  His next book, "Sarah in the In-Between", relating his mother's elder years' adventures in non-local consciousness will be published by Spiegel & Grau in 2027.  Neil's WebsiteNeil's Book: Notes On ComplexityMore on Interstitum:NY TimesRadiolabForthcoming:Phenomena Healing PodcastPhenomena Healing DocumentarySupport the show

Most of us know what we should be doing. The harder question is why we can't actually do it. In this episode, Dr. Rachel Goldman joins Kati to talk about food noise, GLP-1s, cognitive behavioral therapy, and the small mindset shifts that change everything. Dr. Rachel is a clinical psychologist, clinical assistant professor of psychiatry at NYU Grossman School of Medicine, and author of the new book When Life Happens. She specializes in cognitive behavioral therapy, stress, and the treatment of eating disorders and obesity, and she runs a private practice in New York City. Today we talk about why your brain defaults to worst-case scenario (it's survival wiring, not a personal flaw), the one-word shift that interrupts all-or-nothing thinking, and the cognitive distortions quietly running your day. Dr. Rachel walks us through what food noise actually is and why some people genuinely don't have it, how GLP-1 medications are changing the conversation around eating disorders and obesity treatment, and what most people misunderstand about both. We get into why the body sends signals that get louder until you finally listen, why "finding balance" is setting you up to fail, and the reframe that finally helped Dr. Rachel stop cancelling on herself. We also go personal: how a clinical psychologist talks to her own kids about mistakes, what's actually in her toolbox when life feels too heavy, and the moment that changed how she thinks about self-care. If you've been doing the work, reading the books, going to therapy, and still feel like you can't get traction, this conversation gives you a place to start that doesn't require overhauling your life. Shopping with our sponsors helps support Ask Kati Anything BiOptimizers Magnesium Breakthrough — Go to bioptimizers.com/kati and use code KATI for 15% off your entire order, plus a FREE bottle of MassZymes Reddit — Download the Reddit app today! Chapters (0:00) Why you keep starting over (1:30) Why she wrote this book (4:18) What a mindset shift looks like (6:00) All-or-nothing thinking (8:30) The one small thing rule (12:02) Worst-case scenario thinking (14:30) The thoughts running your day (16:13) When therapists share personal stuff (18:30) Did training prepare her for motherhood? (24:00) Working in obesity treatment (30:00) GLP-1s and food noise explained (37:20) Dance, eating disorders, the wake-up (42:30) Your body is sending signals (44:30) Managing a book launch and two kids (48:00) The Casey Neistat self-care moment (52:20) Why finding balance fails (55:00) Poker chips and resilience (58:30) What she hopes her kids learn (1:02:30) Dr. Rachel's three tools (1:04:30) Where to find Dr. Rachel Dr. Rachel's book When Life Happens is out now: whenlifehappensbook.comFind Dr. Rachel on Instagram: @drrachelnyc More from Kati YouTube: youtube.com/c/katimorton Instagram: @katimorton Kati's BooksWhy Do I Keep Doing This? geni.us/XoyLSQTraumatized geni.us/Bfak0jAre u ok? geni.us/sva4iUY Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this Mind Moments episode, Scott Grossman, MD, assistant professor of neurology and ophthalmology at NYU Grossman School of Medicine, discusses emerging research on inter-eye retinal nerve fiber layer (RNFL) asymmetry as a biomarker of prior optic neuritis in pediatric-onset multiple sclerosis (POMS). Drawing from data presented at the 2026 American Academy of Neurology Annual Meeting, Grossman explains how optical coherence tomography (OCT) may help improve diagnostic confidence in pediatric MS by identifying remote optic nerve injury, while also outlining how a 4-micron inter-eye RNFL difference emerged as the optimal threshold in this cohort. The conversation also explores the role of OCT within the updated 2024 McDonald Criteria, the feasibility of integrating OCT into routine neurology practice, challenges surrounding normative pediatric OCT data, and future research directions involving visible light OCT and broader population datasets. Looking for more Multiple Sclerosis discussion? Check out the NeurologyLive® Multiple Sclerosis clinical focus page.Episode Breakdown: 1:15 – Optic nerve involvement and updated MS diagnostic criteria  3:20 – Pediatric RNFL asymmetry thresholds and interpretation of study findings 5:15 – Clinical implications of OCT biomarkers in pediatric-onset MS  6:40 – Neurology News Network  8:40 – Feasibility of incorporating OCT into neurology and MS practice  10:15 – Future research directions, including normative data and visible light OCT The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves AXS-05 as New Treatment for Alzheimer Disease Agitation FDA Approves Ocrelizumab for Pediatric Patients With Relapsing-Remitting Multiple Sclerosis Efgartigimod Gains FDA Approval as First Treatment for Seronegative Forms of Myasthenia Gravis Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Food allergy diagnosis is still too often driven by tests instead of history, leading to unnecessary restriction and missed opportunities for targeted care. In this episode, we invite Dr. Anna Nowak-Wegrzyn, a leading researcher in food allergy and Director of Pediatric Allergy and Immunology Division at NYU Grossman School of Medicine, to help unpack the core clinical challenge of distinguishing true food allergy from sensitization, and discuss practical approaches to history-directed testing, component-resolved diagnostics, baked milk and egg tolerance, oral immunotherapy, and eosinophilic esophagitis recognition in atopic patients. We also highlight how primary care can help identify higher-risk patients earlier, improve referral decisions, and support more precise management using evolving diagnostic tools. For clinicians caring for children and adults with allergy, this conversation offers actionable insights for diagnosis, risk stratification, and day-to-day management. References and resources: https://www.thermofisher.com/phadia/us/en/resources/immunocast/eoe-food-allergy-diagnostics-update.html?cid=0ct_3pc_05032024_9SGOV4

NYC Health and Hospitals announced plans to shut down a storied program at Bellevue Hospital that treats torture survivors, citing tenuous federal funding and the possibility of ICE raids at the hospital. Allen Keller, M.D., associate professor of medicine and population health at NYU Grossman School of Medicine and founder of Bellevue's Program for Survivors of Torture, and Ibrahim, former patient at Bellevue's Program for Survivors of Torture, discuss the impact of the program and why they're fighting to keep it open. Photo: Bellevue Hospital - NYC (Credit: ajay_suresh via Wikimedia Commons, CC BY 2.0)

This content has been funded by AstraZeneca, and is intended for healthcare professionals. The content in this podcast is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment, nor to promote any specific product or therapy.  The guests have been compensated by AstraZeneca for their participation. The views expressed are their own and do not necessarily reflect those of the AMJ or AstraZeneca. If you choose to act on information discussed here, you do so at your own discretion. Description: As homologous recombination deficiency (HRD) testing becomes increasingly embedded in ovarian cancer pathways, clinicians need clear, operational guidance. This episode brings together expert perspectives on selecting tests, understanding outputs, and integrating results into guideline-aligned care.  Learn: ·       HRD basics in plain language: what you're measuring and why ·       Test selection and reporting nuances that affect downstream decisions ·       Workflow design across oncology, pathology, and genetics ·       Applying results to maintenance strategies and patient conversations  Speakers: 1.     Rebecca Arend, Associate Director for Clinical Research, UAB O'Neal Comprehensive Cancer Center; Endowed Professor of Gynecologic Oncology, University of Alabama, USA. 2.   Thomas Krivak, Director, Division of Gynecologic Oncology; Chief Surgeon, West Penn Hospital, USA. 3.    Bhavana Pothuri, Gynecologic Oncologist, NYU Langone Health; Associate Professor, Department of Obstetrics and Gynecology, NYU Grossman School of Medicine, USA.

Guest: Dr. Amanda Lund is an Associate Professor at the NYU Grossman School of Medicine. She discusses how the lymphatic vasculature serves as a critical and dynamic interface between tissues and the immune system, challenging the traditional view of lymphatics as passive conduits. She highlights how lymphatic vessels actively regulate immune responses by controlling fluid flow, antigen transport, and cell migration during infection and cancer, and explores their emerging roles in shaping immunity and tissue biology. Featured Products and Resources: Download the free cell separation e-book from STEMCELL Technologies. Learn how to isolate highly pure immune cells and efficiently process human samples. The Immunology Science Round Up MHC I Shapes CD4 Immunity– MHC class I unexpectedly regulates CD4+ T cell cytotoxicity by protecting target cells from ferroptosis. Re-Emergence of Oropouche Virus – Scientists have mapped the resurgence and long-term burden of Oropouche virus, revealing widespread infection across Latin America. Scalable In Vivo T Cell Engineering – A new in vivo CRISPR-based system enables precise, stable generation of CAR T cells. Gut–Brain Axis in Autoimmunity – Intestinal epithelial cells initiate autoimmune neuroinflammation via TH17 cell responses that migrate to the central nervous system. Image courtesy of Dr. Amanda Lund. Subscribe to our newsletter! Never miss updates about new episodes. Subscribe

In this episode of Mom Curious, Daniella sits down with clinical psychologist Dr. Rachel Goldman to talk about her new book, When Life Happens, and the tools we actually need to navigate stress, uncertainty, and emotional overwhelm. As a specialist in cognitive behavioral therapy with a holistic approach to health, Dr. Rachel works at the intersection of mental health, behavior change, and real life. This conversation offers practical ways to manage stress, shift patterns, and move through difficult moments with more clarity, flexibility, and self-compassion. GUEST BIO Dr. Rachel Goldman is a clinical psychologist, speaker, and author specializing in cognitive behavioral therapy and a holistic approach to health. She is a Clinical Assistant Professor in the Department of Psychiatry at NYU Grossman School of Medicine and maintains a private practice in New York City. A sought-after media expert, Dr. Rachel has been featured in outlets including TIME, The New York Times, CNN, and USA Today, and has appeared on major stages and podcasts. She is the author of When Life Happens, a book focused on helping people manage stress and create meaningful, lasting change. AFFILIATE LINKS & MENTIONS Dr. Rachel's highly anticipated debut book WHEN LIFE HAPPENS Book your Podcast Recording at Hoff Studios $30 off WTHN Acupuncture Booking with code MOMCURIOUS30 More Info on EVOLV GLP-1 Supplements Follow our Guest @drrachelnyc on Instagram Follow @momcurious and the host @daniellarabbani on Instagram Subscribe, rate, and review - it helps get the word out about the show and keeps these conversations going. Learn more about your ad choices. Visit megaphone.fm/adchoices

iuscan.org.   --> not for profit discussed in this podcast episode.    Title: Intestinal Ultrasound for Diagnosis and Management of Inflammatory Bowel Disease Target Audience This activity is directed to physicians, medical students, nurse practitioners, nurses, and physician assistants. Objectives: Upon completion of this activity, participants should be able to: Review how Inflammatory Bowel Disease (IBD) is traditionally diagnosed and managed.  Review how intestinal ultrasound works and how it has been used to diagnose and manage IBD and review the data.  Review the benefits and limitations of intestinal ultrasound for IBD management and diagnosis.  Course Directors: Tony R. Tarchichi MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine. No relationships with industry relevant to the content of this educational activity have been disclosed. Michael Dolinger MD - Assistant Professor, Department of Pediatrics, NYU Grossman School of Medicine Dr. Dolinger disclosed he is a consultant for Abbvie, Pfizer, Johnson & Johnson, Celltrion, Takeda, Sanofi and Samsung Corp. Conflict of Interest Disclosure: No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.   Accreditation Statement: In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity. Disclaimer Statement: The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses. Released 3/23/26, Expires 3/23/28 The direct link to the course is provided below: Coming soon!

Welcome to Transmission Interrupted! In this episode, host Jill Morgan sits down with the principal investigators of NETEC—Dr. Aneesh Mehta, Dr. Vikramjit Mukherjee, and Dr. John Lowe—to reflect on a decade of advancing special pathogen preparedness across the U.S. healthcare system. Together, they revisit the origins of NETEC, tracing back to the transformative events of the 2014 Ebola outbreak, and share their unique journeys as infectious disease experts, critical care clinicians, and scientists on the front lines. The conversation dives into the challenges and lessons learned while building a national network equipped for high-consequence infectious diseases, the evolution from isolated specialty units to a system-wide approach, and the critical importance of healthcare worker safety. You'll hear insights on what it takes to maintain readiness in a landscape of ever-changing threats, the value of interdisciplinary collaboration, and a call to expand this “tight-knit club” of preparedness champions. Whether you're a healthcare professional, public health advocate, or just curious about how the U.S. prepares for medical crises, this episode delivers an inspiring look at the past, present, and future of special pathogen response—and why it matters to us all. Guests John-Martin Lowe, PhD John-Martin Lowe, PhD, is the director of the Global Center for Health Security, assistant vice chancellor for health security training and education, and professor of Environmental, Agricultural and Occupational Health at the University of Nebraska Medical Center. At the University of Nebraska Medical Center, he leads research and training initiatives to advance environmental risk assessment and infection control for high consequence pathogens. As a virologist and environmental exposure scientist, Dr. Lowe has worked extensively throughout the U.S., Africa, Asia and Europe as an educator, researcher, and in health emergency risk management related to infectious disease, infection control and emergency response. As a professor of environmental and occupational health, his expertise focuses on infectious disease risk assessment and management of risk for clinical, community and industrial environments. Dr. Lowe also has extensive experience in emerging pathogens and health security. He is co-PI for the U.S. National Emerging Special Pathogens Training and Education Center, established an international network for emerging infectious diseases, and served lead investigator for a multi-country bio-surveillance network in Africa. He has experience in a broad range of health security topics from surveillance, public health response and clinical response to health emergencies. Dr. Lowe led successful COVID-19 efforts in 2020 at the National Quarantine Unit and Nebraska Biocontainment Unit to provide monitoring and care for repatriated U.S. citizens exposed to and infected with SARS Coronavirus 2. He also led early and continued efforts to characterize the transmission dynamics of SARS Coronavirus 2 which were presented to in a joint meeting hosted by the Academy of Medicine and American Public Health Association on April 15, 2020. Dr. Aneesh Mehta, MD, FIDSA, FAST Aneesh Mehta is a Professor of Medicine and of Surgery at Emory University School of Medicine, and also serves as the Chief of Infectious Diseases Services and Assistant Director of Transplant Infectious Diseases at Emory University Hospital. He is a board-certified infectious diseases physician, who received an MD from the University of Oklahoma and completed Internal Medicine and Infectious Diseases training at Emory University. Aneesh has been one of the core physicians of the Emory Serious Communicable Diseases Unit (SCDU) since 2009. He was admitted physician for Emory's first patient with Ebola Virus Disease and was highly involved in care of the four patients with EVD, one patient with Lassa Fever, and several PUIs cared for by the Emory SCDU. During the Ebola activation, Aneesh was involved in all aspects of unit management, patient care, laboratory handling, and research. Aneesh is a co-Principal Investigator at NETEC. He also has been involved in development of the Special Pathogens Research Network Biorepository and evaluation of Medical Countermeasures. Vikramjit Mukherjee, MD, FRCP (Edin) Vikramjit Mukherjee is an intensive care physician who serves as the Chief of Critical Care at NYC Health+Hospitals/Bellevue. He also is the Chief of Bellevue's Special Pathogens Program. Dr. Mukherjee is an Associate Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at the NYU Grossman School of Medicine. Dr. Mukherjee serves as co-Principal Investigator for NETEC, as a steering committee member for the National Special Pathogens System of Care, and as an executive member of the Task Force for Mass Critical Care. His research interests include special pathogen preparedness and mass critical care. Vikramjit Mukherjee completed his medical training at Armed Forces Medical College, India, before arriving in the United States. Here, he completed his residency and chief residency at Georgetown University/Washington Hospital Center and fellowship and chief fellowship in Pulmonary and Critical Care Medicine at New York University Medical Center. Following completion of training in 2015, he joined faculty in the Division of Pulmonary, Critical Care and Sleep Medicine at New York University Grossman School of Medicine. Host Jill Morgan, RN Emory Healthcare, Atlanta, GA Jill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI). Resources About NETECNETEC LeadershipTransmission Interrupted PodcastNational Special Pathogen System (NSPS)NETEC Resource Library About NETEC A Partnership for Preparedness The National Emerging Special Pathogens Training and Education Center's mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources. Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems. For more information visit NETEC on the web at www.netec.org. NETEC Consultation Services Assess and Advance Your Readiness for Special Pathogens with Free, Expert Consulting. NETEC offers free virtual and onsite readiness consulting to help health care facilities and EMS agencies prepare for special pathogen events. Our targeted support services are delivered by experts selected and assigned to each inquiry based on the unique needs of your organization. Have a question? Ask a NETEC expert. For more information visit: netec.org/consulting-services.

In our February episode, we marked American Heart Month with Dr. Michael Ghalchi, the founder and medical director of Manhattan Cardiovascular Associates and a Clinical Instructor in the Department of Medicine at NYU Grossman School of Medicine. Dr. Ghalchi explained the importance of regular screenings and shared lifestyle habits that can keep your heart strong. In this month's Key Note, Dr. Ghalchi reviews the key health numbers to aim for to help you stay on track and live your best life.  The Takeaway We want to hear from you! Please complete our survey: 1199SEIUBenefits.org/member-feedback. Drop us a line at our social media channels: Facebook // Instagram // YouTube. Find out where you stand heart-wise by making an appointment with your primary care physician. Don't have one? Find one at our Provider Directory: www.1199SEIUBenefits.org/find-a-provider.  Visit the Healthy Living Resource Center for wellness tips, information and resources; www.1199SEIUBenefits.org/healthyliving. Get to know your numbers at www.1199SEIUBenefits.org/healthyhearts. Need support managing chronic conditions such as type 2 diabetes, hypertension or overweight? Learn about our partnerships: visit www.1199SEIUBenefits.org/the-choice-is-yours/ Browse healthy recipes and meal-prep tips at www.1199SEIUBenefits.org/food-as-medicine. Get inspired by fellow members through our Members' Voices series: www.1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: www.1199SEIUBenefits.org/videos. Visit our  YouTube channel to view a wide collection of healthy living videos: www.youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: www.1199SEIUBenefits.org/wellnessevents. Guest Bio Michael Ghalchi, MD, FACC is a board-certified cardiologist and the founder and medical director of Manhattan Cardiovascular Associates, a New York City–based cardiology practice dedicated to making high-quality cardiovascular diagnostics and care accessible, efficient and patient-centered. He is also a Clinical Instructor in the Department of Medicine at NYU Grossman School of Medicine. He graduated summa cum laude from the University of Pennsylvania and earned his medical degree from the New York University School of Medicine.   At Manhattan Cardiovascular Associates, Dr. Ghalchi focuses on delivering timely, evidence-based cardiovascular care supported by advanced in-office diagnostics, streamlined access and a concierge-level patient experience. His clinical work emphasizes early detection, accurate diagnosis and thoughtful management of cardiovascular disease across a broad patient population. Dr. Ghalchi is also the founder and Medical Director of Apollo 360 Health, a digital preventive-care platform designed to extend high-quality cardiovascular and lifestyle medicine beyond the clinic walls. Apollo 360 Health integrates remote monitoring, data-driven insights and multidisciplinary coaching to help patients proactively manage risk factors, improve outcomes and sustain long-term health. Across both organizations, Dr. Ghalchi's mission is to modernize cardiovascular care by combining rigorous clinical standards with innovative delivery models — ensuring patients receive the right care, at the right time, in the setting that best supports lasting health.

Bipin Subedi, MD, explores how health systems can better care for patients with severe mental illness who cycle between hospitals, homelessness, addiction, and the justice system. He argues that acute inpatient treatment, while essential, is rarely sufficient on its own. Preventing the revolving door of repeated hospitalizations requires psychiatry to extend beyond hospital walls and build integrated systems that follow patients into the community.Drawing on his leadership at NYU Bellevue and his background in forensic psychiatry, Dr. Subedi describes a model of care built on sustained relationships, flexibility, and continuity. He reflects on how programs like transitional housing and mobile post-discharge support can provide the “scaffolding” patients need when insight and executive function are impaired by psychosis. The conversation closes with practical guidance on strengthening medication adherence—particularly through thoughtful use of long-acting injectables—and on meeting patients where they are to advance more humane, effective care.Bipin Subedi, MD, is Associate Professor of Psychiatry at NYU Grossman School of Medicine and Chief of Psychiatry at NYU Bellevue Hospital. He is a forensic psychiatrist with prior leadership experience in New York City's jail system.▶️ Watch Insights on Psychiatry on YouTube01:36 Bellevue's Mission and Rising Clinical Complexity04:43 Extending Care Beyond the Hospital Walls05:15 Bridge to Home and Transitional Stabilization10:44 Forensic Psychiatry and the Justice System14:17 Psychosis and Impaired Insight15:53 Post-Discharge Scaffolding and Critical Time Intervention18:47 Preventing Relapse with Long-Acting Injectables22:36 Meeting Patients Where They AreThis episode is intended for psychiatrists, mental health clinicians, and health system leaders interested in serious mental illness and innovative models of integrated community care.This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle

Katlyn Nemani, MD, explores how autoimmune and inflammatory brain disorders can present as first-episode psychosis—and why some patients diagnosed with schizophrenia may actually have a treatable immune-mediated illness. She explains the clinical features that should prompt suspicion for autoimmune psychosis, including subacute onset, subtle neurologic signs, and poor response to antipsychotics, even when standard imaging and antibody tests are unrevealing.Dr. Nemani also discusses the limits of current biomarkers, how to think clinically when diagnostic certainty is incomplete, and why early immunotherapy can dramatically alter outcomes. The conversation closes with a forward-looking discussion of emerging research suggesting that a meaningful subset of schizophrenia-like illness may ultimately be reclassified as autoimmune in origin.Katlyn Nemani, MD, is a Research Assistant Professor in the Departments of Psychiatry and Neurology at NYU Grossman School of Medicine and a graduate of NYU's combined Neurology-Psychiatry residency program.▶️ Watch Insights on Psychiatry on YouTube00:00 When Psychosis May Be an Autoimmune Disease01:18 Early Psychiatric Symptoms of Autoimmune Encephalitis02:47 Why Subtle Neurologic Clues Matter04:00 A Case of Rapidly Reversible Psychosis06:37 The Limits of Antibody Testing07:51 Why Early Treatment Changes Outcomes08:18 Rethinking the Heterogeneity of Schizophrenia09:31 How Common Is Autoimmune Contribution to Psychosis?10:48 Network-Level Brain Effects and Open Research QuestionsThis episode is intended for psychiatrists, neurologists, and other clinicians interested in psychosis, neuroinflammation, and complex diagnostic presentations at the psychiatry–neurology interface.This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle

In this episode of One in Ten, host Teresa Huizar speaks with Dr. Robin Ortiz, an assistant professor in the Department of Pediatrics at NYU Grossman School of Medicine, about neglect recurrence in child abuse cases. Dr. Ortiz discusses the factors contributing to neglect recurrence, including adverse childhood experiences (ACEs), environmental influences, and societal factors. They explore the gaps in the literature, the complexities of defining neglect, and the need for tailored interventions. Findings from Dr. Ortiz's recent research indicate that various risk factors exist at the child, family, community, and policy levels, and they emphasize the importance of societal investment in mental health, substance abuse treatment, domestic violence intervention, and financial stability to prevent neglect. The episode highlights the need for a comprehensive approach to support families and break the cycle of neglect.  Time Stamps  Time Topic 00:00 Introduction and Guest Introduction 00:13 Understanding Neglect Recurrence 01:11 Guest's Background and Research Focus 03:11 Literature Review on Child Maltreatment Recurrence 05:33 Defining Neglect and Its Challenges 10:08 Study Hypotheses and Findings 18:26 Risk Factors for Neglect Recurrence 25:07 Impact of Services on Neglect Recurrence 38:24 Policy Implications and Societal Responsibility 41:03 Conclusion and Takeaways ResourcesChild, Family and Societal Factors Related to Neglect Recurrence After CPS Investigation - Robin Ortiz, Vincent J. Palusci, 2025Support the showDid you like this episode? Please leave us a review on Apple Podcasts.

Welcome to American Heart Month, the perfect opportunity to focus on protecting our cardiovascular health to help ensure we can continue to do the things we love with the people we love. Experts estimate that heart disease is 80 percent preventable through early detection and simple lifestyle changes. So we are fortunate to be joined by Dr. Michael Ghalchi, the founder and medical director of Manhattan Cardiovascular Associates and a Clinical Instructor in the Department of Medicine at NYU Grossman School of Medicine. Dr. Ghalchi discusses the importance of regular screenings, symptoms to watch for and sustainable habits you can adopt to support your heart health all year long.   The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Find out where you stand heart-wise by making an appointment with your primary care physician. Don't have one? Find one at our Provider Directory: www.1199SEIUBenefits.org/find-a-provider. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Get to know your numbers at www.1199SEIUBenefits.org/healthyhearts. Need support managing chronic conditions such as type 2 diabetes, hypertension or overweight? Learn about our partnerships: visit www.1199SEIUBenefits.org/the-choice-is-yours/ Browse healthy recipes and meal-prep tips at 1199SEIUBenefits.org/food-as-medicine. Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents. Guest Bio Michael Ghalchi, MD, FACC is a board-certified cardiologist and the founder and medical director of Manhattan Cardiovascular Associates, a New York City–based cardiology practice dedicated to making high-quality cardiovascular diagnostics and care accessible, efficient and patient-centered. He is also a Clinical Instructor in the Department of Medicine at NYU Grossman School of Medicine. He graduated summa cum laude from the University of Pennsylvania and earned his medical degree from the New York University School of Medicine. At Manhattan Cardiovascular Associates, Dr. Ghalchi focuses on delivering timely, evidence-based cardiovascular care supported by advanced in-office diagnostics, streamlined access and a concierge-level patient experience. His clinical work emphasizes early detection, accurate diagnosis and thoughtful management of cardiovascular disease across a broad patient population. Dr. Ghalchi is also the founder and Medical Director of Apollo 360 Health, a digital preventive-care platform designed to extend high-quality cardiovascular and lifestyle medicine beyond the clinic walls. Apollo 360 Health integrates remote monitoring, data-driven insights and multidisciplinary coaching to help patients proactively manage risk factors, improve outcomes and sustain long-term health. Across both organizations, Dr. Ghalchi's mission is to modernize cardiovascular care by combining rigorous clinical standards with innovative delivery models — ensuring patients receive the right care, at the right time, in the setting that best supports lasting health.

Stigma. Discomfort. High pitched feedback. These are some reasons that people opt out of wearing hearing aids. Yet, hearing loss has been linked to dementia and social isolation, and one-third of Americans aged 70 and older suffer from the condition. Even young people are not immune: 20% of Gen Z suffers from noise-induced hearing problems. We talk about innovations in treating hearing loss. Have you resisted wearing a hearing aid? Guests: Nicholas S. Reed, adjunct associate professor, otolaryngology, NYU Grossman School of Medicine, Reed is an audiologist and epidemiologist who has studied the links between hearing loss and dementia Christopher Null, technology journalist, He covers hearing aids for WIRED Dr. Konstantina Stankovic, ear and skull base surgeon and auditory neuroscientist, Stanford Medical School. Learn more about your ad choices. Visit megaphone.fm/adchoices

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David P. Hudesman, MD Ulcerative colitis treatment continues to evolve with a growing range of targeted therapies, from S1P modulators to JAK inhibitors. Joining Dr. Peter Buch to discuss how clinicians can personalize care based on disease severity, safety profiles, and patient response is Dr. David Hudesman. He's a Professor in the Department of Medicine at NYU Grossman School of Medicine and the Director of NYU Langone's Inflammatory Bowel Disease Center.

The endocrine system consists of eight major organs that produce and regulate hormones, the chemical messengers that keep the body in balance. Hormones quietly orchestrate everything from our energy and metabolism to mood, sleep, and resilience, acting as an internal communication network that responds to stress, environment, and lifestyle. From cold plunges and saunas to endocrine-disrupting chemicals, even small daily inputs are said to shift this delicate signaling. How does stress really affect our bodies? Does “adrenal fatigue” exist? Is it actually possible to “biohack” our hormones?In this episode, we are joined by Dr. Priya Jaisinghani, MD, ABIM, DABOM, a triple board-certified Endocrinology, Obesity Medicine, and Internal Medicine physician from New York City.Dr. Jaisinghani received her MD from Rutgers/Robert Wood Johnson Medical School, where she also completed her Internal Medicine Residency, Endocrinology and Obesity Medicine Fellowships at Weill Cornell Medicine. Currently, Dr. Jaisinghani is a Diabetes, Metabolism, and Obesity Medicine attending physician at NYU Langone Health, Clinical Assistant Professor of Medicine at NYU Grossman School of Medicine, and a Medical Unit Contributor at ABC News.Dr. Jaisinghani has been featured on CNN, Rolling Stone, The New York Times, The Wall Street Journal, Men's Health, FOX 5 News, and Medscape,Follow Friends of Franz Podcast: Website, Instagram, FacebookFollow Christian Franz (Host): Instagram, YouTube

Ayana Jordan, MD, PhD, discusses how precision psychiatry must expand beyond biology to address the social, cultural, and structural realities shaping addiction and mental health care for historically underrepresented patients. The conversation explores how trauma, poverty, housing instability, health literacy, and stigma interact with substance use and serious mental illness—and why traditional clinic-based models often fail to meet patients where they are.Dr. Jordan describes the work of the Jordan Wellness Collaborative, including partnerships that integrate addiction treatment into primary care, community settings, and faith-based institutions. She explains how peer facilitators, housing support, and trusted community spaces can dramatically improve engagement, retention, and outcomes. Looking ahead, she reflects on how emerging tools—from AI-supported care models to novel treatments for addiction—may further transform access and equity in psychiatric care.Ayana Jordan, MD, PhD, is the Barbara Wilson Professor of Psychiatry at NYU Grossman School of Medicine and Principal Investigator of the Jordan Wellness Collaborative.TOPICSExpanding precision psychiatry beyond biological modelsStructural barriers to care: housing, literacy, and stigmaAddiction treatment for historically underrepresented communitiesIntegrating care into primary care, community, and faith-based settingsThe role of peer facilitators and lived experience in treatmentTrust, safety, and engagement for patients with complex needsFuture directions: AI, novel addiction treatments, and workforce trainingWatch Insights on Psychiatry on YouTubeSenior Producer: Jon Earle

To kick off Season 4, Charles Marmar, MD, explains how precision psychiatry is reshaping the way clinicians and researchers think about diagnosis, treatment selection, and the underlying biology of psychiatric disorders. This conversation is a overview of where the field stands today—including emerging molecular markers, biologically informed subtypes, and new translational approaches inspired by oncology and other precision-based specialties.Dr. Marmar is Chair of Psychiatry at NYU Grossman School of Medicine, and Director of the Center for the Study of Alcohol Use Disorder and Traumatic Stress.In this episode, he outlines current work on:Molecular and genomic signatures that may distinguish patient subtypesClinical trials examining targeted treatments for alcohol use disorderThe development of proxy “brain biopsy” methods such as exosomal analyses and iPSC-derived organoidsHow converging biological data could eventually support more individualized treatment planningThis discussion reflects ongoing efforts at NYU Langone Health to move psychiatry toward a more mechanism-based, biologically grounded model of care, while acknowledging the complexity and early stage of the work. For clinicians, scientists, and trainees, the episode provides a clear snapshot of the major directions shaping precision psychiatry today.CHAPTERS00:00 Introduction: The Challenge in Psychiatry00:34 Meet the Experts01:07 Understanding PTSD: Types and Subtypes04:47 Current Research and Innovations06:19 The Future of Psychiatry: Precision Medicine09:34 Case Study: Personalized Treatment Success11:33 Conclusion: The Path ForwardVisit our website for more Insights on Psychiatry.Watch this episode on YouTubeExecutive Producer: Jon Earle

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aasma Shaukat, MD, MPH Blood-based colorectal cancer screening is entering a new era with FDA-approved and emerging tests like Shield and Simple Screen. Alongside updated stool-based options such as Cologuard Plus and CRC-PREVENT, clinicians now have a broader landscape of noninvasive tools to consider and discuss with their patients. Joining Dr. Peter Buch to talk about current recommendations and potential future directions for colorectal cancer screening is Dr. Aasma Shaukat. Dr. Shaukat is the Robert M. and Mary H. Glickman Professor of Medicine and a Professor of Population Health at NYU Grossman School of Medicine, as well as the Director of Outcomes Research in the Division of Gastroenterology and Hepatology at NYU Langone Health. She's also a co-author of a recent review on blood tests for colorectal cancer.

Dr. Maria Janakos is a sports medicine physiatrist at NYU and a Clinical Assistant Professor at the NYU Grossman School of Medicine. She completed her residency at the University of Louisville and a Primary Care Sports Medicine Fellowship at Morristown Medical Center in New Jersey. Her clinical interests include concussion management, orthobiologics, musculoskeletal ultrasound, and event coverage. Dr. Janakos is actively involved in medical education at NYU, teaching medical students, residents, and fellows through lectures, hands-on training, and mentorship. At NYU, she is an active member of the NYU Concussion Center, where she regularly lectures on various concussion topics at both local and national levels. She specializes in the care of patients with acute concussions, treating individuals from adolescence through age 45. Part 2 The discussion included the following topics: challenges that patients face during the recovery period; factors determining treatment outcomes; preventing concussions; composition of the interdisciplinary treatment team; and the role of technology in treatment interventions.    

Dr. Maria Janakos is a sports medicine physiatrist at NYU and a Clinical Assistant Professor at the NYU Grossman School of Medicine. She completed her residency at the University of Louisville and a Primary Care Sports Medicine Fellowship at Morristown Medical Center in New Jersey. Her clinical interests include concussion management, orthobiologics, musculoskeletal ultrasound, and event coverage. Dr. Janakos is actively involved in medical education at NYU, teaching medical students, residents, and fellows through lectures, hands-on training, and mentorship. At NYU, she is an active member of the NYU Concussion Center, where she regularly lectures on various concussion topics at both local and national levels. She specializes in the care of patients with acute concussions, treating individuals from adolescence through age 45.   Part 1 The discussion included the following topics: age groups of patients receiving treatment; types of cases treated; distinguishing medical terms for brain injuries; common symptomology; patient journey from initial assessment through recovery; and collaboration with patients' families.  

People who live the longest aren't always the ones with the “perfect” body weight. In fact, research suggests that being slightly overweight can actually increase your life expectancy. It sounds counterintuitive, but the science may surprise you. Listen as I explain what's really going on. https://healthland.time.com/2013/01/02/being-overweight-is-linked-to-lower-risk-of-mortality/ Ever since the dawn of the Internet, we've been told to guard against hackers — but today's biggest threat isn't hacking, it's scamming. Cybercriminals are more cunning than ever, tricking millions into giving up money and information every day. If you think you are too clever to be taken by cyber-scammers, think again. Eric O'Neill — former FBI undercover operative, national security attorney, and cybersecurity strategist — reveals how modern scams work and how to stop them before they get to you. He's the author of Spies, Lies, and Cybercrime: Cybersecurity Tactics to Outsmart Hackers and Disarm Scammers (https://amzn.to/4nRvvv1). Imagine medicine without X-rays, CT scans, or MRIs. It's impossible — these imaging breakthroughs revolutionized how doctors diagnose and treat disease. Yet not long ago, the idea of seeing inside the body without a single incision was pure fantasy. Dr. Daniel K. Sodickson, chief of innovation in radiology at NYU Grossman School of Medicine and author of The Future of Seeing: How Imaging Is Changing Our World (https://amzn.to/3KNz3zS), shares the fascinating story of how imaging transformed modern medicine — and what's coming next. Sarcasm might seem like just a clever way to joke around but it's actually good exercise for your brain. Using and understanding sarcasm requires multiple parts of your mind to work together. Listen as I explain why being sarcastic might make you sharper. https://www.hbs.edu/faculty/Pages/item.aspx?num=49283&utm Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Zhu is a clinical assistant professor in the Department of Rehabilitation Medicine at NYU Grossman School of Medicine. Her clinical interests include the management of a range of symptoms associated with cancer and its treatment, including weakness, pain, neuropathy, and limited range of motion. Throughout her career, she has been dedicated to proactive healthcare engagement, working closely with a team to provide comprehensive care. Her practice emphasizes patient education, along with helping individuals understand the causes of their symptoms and the changes their bodies are undergoing. She received her medical degree from Rutgers New Jersey Medical School. She then went on to complete a PM&R Residency at NYU Grossman School of Medicine and a Cancer Rehabilitation Fellowship at the University of Miami.    Part 1 The discussion included the following topics: primary purpose of this offering, educational objectives. Summit format, target audience, topics to be covered, and expected outcomes for participants.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "Building Safer, Smarter, and More Personalized Epilepsy Care," Orrin Devinsky, MD, discusses major areas of progress and ongoing challenges in epilepsy care. Devinsky, a professor in the departments of neurology, neurosurgery, and psychiatry at NYU Grossman School of Medicine, reflects on how the treatment landscape has evolved in recent years, including advances in medication, awareness of SUDEP, and patient counseling. Devinsky also weighs in on the current treatment hierarchy for antiepileptic drugs and whether first-line therapeutic strategies should change. Additional discussion touches on the state of gene therapy development, the need for greater research in disease prevention, the implications of GLP/GIP agents in neurological care, and how neurodevelopmental management is advancing for pediatric patients with epilepsy. Looking for more Epilepsy discussion? Check out the NeurologyLive® Epilepsy clinical focus page. Episode Breakdown: 0:55 – How epilepsy care has evolved and where progress has been made 5:30 – Whether first-line therapy choices for epilepsy should be re-evaluated 8:35 – Why gene therapy progress has been slower than expected in epilepsy 12:05 – Neurology News Minute 14:10 – What areas of epilepsy research deserve greater attention and funding 17:10 – How GLP/GIP agents could intersect with neurological and epilepsy care 20:00 – How clinicians can better address neurodevelopmental challenges in patients with epilepsy The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: Neflamapimod Advances to Phase 3 Trial in Dementia With Lewy Bodies After Positive RewinD-LB Results FDA Delays Review Deadline for Hunter Syndrome Agent Tividenofusp Alfa FDA Clears Roche's Elecsys pTau181 Test for Ruling Out Alzheimer-Related related Amyloid Pathology Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

In this episode, we sit down with Dr. Alexandra Flamm, MD, Associate Professor in the Ronald O. Perelman Department of Dermatology at the NYU Grossman School of Medicine and Program Director of the NYU Dermatology Residency. She is a board-certified dermatologist and dermatopathologist with expertise in eczema, contact dermatitis, and patch testing. Before joining NYU, Dr. Flamm completed her dermatology residency at SUNY Downstate and a dermatopathology fellowship at the University of Pennsylvania. She now leads the NYU Dermatology Residency, an academically robust training program located in the heart of New York City.Dr. Flamm shares her journey through dermatology, what makes the NYU Dermatology Residency a special place to train, and her advice for medical students navigating their own paths into the field. We hope you enjoy!Learn More about NYU Dermatology: Instagram: @nyugsom_dermresWebsite: NYU Dermatology Residency---DIGA Instagram: @⁠⁠derminterest⁠⁠---For questions, comments, or future episode suggestions, please reach out to us via email at ⁠⁠⁠⁠⁠⁠⁠⁠⁠derminterestpod@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠---Music: "District Four" Kevin MacLeod (⁠⁠⁠⁠⁠⁠⁠⁠⁠incompetech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠) Licensed under Creative Commons:By Attribution 4.0 License:⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://creativecommons.org/licenses/by/4.0/

Today's guest is Dr. JR Rizzo, a physician-scientist at the NYU Grossman School of Medicine. His journey is nothing short of remarkable—marked by resilience, determination, and an unwavering drive to make an impact. Despite facing the challenges of a rare vision-loss condition called Choroideremia, Dr. Rizzo has forged a path of perseverance, transforming obstacles into opportunities. In this episode, we'll explore his inspiring story, groundbreaking work, and the lessons he's learned along the way.

Midlife can be the worst when it comes to weight gain. If you are wondering what the ehck is going on with your metabolism and how your hormones might play a role, this episode is for you! I'm joined by Dr. Gillian Goddard, an endocrinologist and an adjunct assistant professor of medicine at the NYU Grossman School of Medicine.  She has more than 15 years of clinical experience and a particular expertise in endocrine diseases affecting women during the reproductive years, pregnancy and through perimenopause.  She helps us understand the nuances of hormone interaction during the menopause transition (which includes all those lovely years before as well known as perimenopause!). We discuss why weight gain happens and what we can do specifically in this time to combat it. START HERE: Download my FREE GLP-1 Success Starter KitLet's talk about whether support for GLP-1 use is right for you—book a free consult HEREMore from Well with Lisa:What To Do When You Overeat–During Weight Loss!  GRAB the free video mini-course! Normally $49– Free for podcast listeners!Your Go-To Meal Guide: grab it HEREReady for your free consult session?  SCHEDULE HERE!Let's be friends! Follow me on instagram:  @well_with_lisaMore from Dr. Gillian Goddard:Substack: savvypatient.substack.comInstagram: @gillianmgoddardBook: Coming Spring 2026!For Dr. Goddard's full bio, check out this episodes web pageDid you know  my listeners are entitled to 10% discount on a fullscript account? Get your Fullscript account HERE10% discount! (pssst: my clients get 25% for life!)Just to be clear: these are NOT weight loss supplements. This is an opportunity to get practitioner grade supplements like magnesium and omega oils at a little discount. Yay!Mixhers! use Lisa10 to stack my discount with the current sale!

What if prostate cancer treatment weren't months of daily radiation—but five ultra-precise sessions guided in real time by MRI? Today, Dr. Michael J. Zelefsky (Professor of Radiation Oncology, NYU Grossman School of Medicine) explains how MRI-LINAC and adaptive planning are redefining accuracy, reducing side effects, and personalizing care. A pioneer behind IMRT and image-guided radiotherapy, Dr. Zelefsky breaks down SBRT vs. IMRT, protons vs. photons, HDR brachytherapy, when to add hormone therapy, and how genomics + AI are shaping what's next.In this conversation, Dr. Zelefsky charts the evolution from long-course radiation to short-course SBRT with outcomes comparable to 7–9 week regimens—thanks to precision imaging and planning. He clarifies where IMRT ends and SBRT begins, why protons haven't shown superiority over photons in prostate cancer, and where HDR brachytherapy (Ir-192) shines—especially as a boost in higher-risk disease. We dig into dose equivalence (why 5×8 Gy can match ~80–90 Gy long-course), risk-based treatment + ADT duration, and how Decipher/Artera scores can refine decisions. Most exciting: MRI-LINAC with continuous motion monitoring keeps the prostate in a virtual “bullseye,” enabling whole-gland treatment with focal boosts today—and potentially true focal therapy tomorrow as biologic imaging and AI mature.Time-Stamped Highlights00:00 – Welcome 02:00 – Why Dr. Zelefsky's work is so respected; career arc and impact04:00 – What changed: CT/MRI planning → 3D-CRT → IMRT → SBRT12:45 – IMRT vs. SBRT: definitions, session counts, who gets what19:10 – Energy sources overview: photons, protons, brachytherapy20:30 – Protons vs. photons: evidence, indications, cost, access24:00 – HDR brachytherapy (Ir-192) as a temporary “in-and-out” boost28:00 – Dose logic: why 5×8 Gy (~40 Gy) ≈ long-course 80–90 Gy29:30 – Risk groups (low/intermediate/high) and when ADT is crucial33:00 – ADT durations (6–36 months): what trials actually showed37:00 – Genomics (Decipher/Artera): resolving risk discrepancies39:00 – What MRI-LINAC adds: real-time adaptive planning43:00 – Continuous Motion Monitoring (CMM): beam stops if target moves47:00 – Treat whole gland + boost the DIL (FLAME study approach)49:00 – Toward focal therapy with better biologic imaging + AI54:00 – How to choose: values, side-effects, lifestyle, comorbidities01:01:00 – Final guidance: don't be overwhelmed—multiple good option

Dr. Steven Flanagan, a nationally renowned expert in the field of traumatic brain injury (TBI), has worked at the Rusk Rehabilitation Institute at NYU Langone Health since 2008. He serves as the Howard A. Rusk Professor of Rehabilitation Medicine and Chairperson of the Department of Rehabilitation Medicine at NYU Grossman School of Medicine. A former President of the American Academy of Physical Medicine & Rehabilitation (PM&R), he is certified by the American Board of PM&R (Brain Injury Medicine). A graduate of the University of Medicine & Dentistry of New Jersey, he completed his medical residency at Mt. Sinai Medical Center/Cabrini, Rehabilitation. Part 3 The discussion covered the following topics: social prescribing, artificial intelligence, reducing length of hospital stay, hospital readmission of patients, and implications of an obesity epidemic.

Dr. Steven Flanagan, a nationally renowned expert in the field of traumatic brain injury (TBI), has worked at the Rusk Rehabilitation Institute at NYU Langone Health since 2008. He serves as the Howard A. Rusk Professor of Rehabilitation Medicine and Chairperson of the Department of Rehabilitation Medicine at NYU Grossman School of Medicine. A former President of the American Academy of Physical Medicine & Rehabilitation (PM&R), he is certified by the American Board of PM&R (Brain Injury Medicine). A graduate of the University of Medicine & Dentistry of New Jersey, he completed his medical residency at Mt. Sinai Medical Center/Cabrini, Rehabilitation. Part 2 The discussion covered the following topics: Rusk's interprofessional approach to patient care, future hiring needs, health promotion efforts to enhance health of staff, preparing Rusk residents for the future in health care, and putting patients first.  

Dr. Steven Flanagan, a nationally renowned expert in the field of traumatic brain injury (TBI), has worked at the Rusk Rehabilitation Institute at NYU Langone Health since 2008. He serves as the Howard A. Rusk Professor of Rehabilitation Medicine and Chairperson of the Department of Rehabilitation Medicine at NYU Grossman School of Medicine. A former President of the American Academy of Physical Medicine & Rehabilitation (PM&R), he is certified by the American Board of PM&R (Brain Injury Medicine). A graduate of the University of Medicine & Dentistry of New Jersey, he completed his medical residency at Mt. Sinai Medical Center/Cabrini, Rehabilitation. Part 1 The discussion covered the following topics: his involvement at Rusk in patient care, research, and professional organizations; impact of COVID on Rusk; traumatic brain injury biomarkers; and recruitment and retention of health professionals.      

Should patients without a terminal illness have the right to die? That's today's poll question at Smerconish.com. Michael dives into the ethical, legal, and emotional complexities of assisted death, with reference to Canada's expanding MAID (Medical Assistance In Dying) program. He also shares moving stories of people and their reasons for wanting to end their lives, plus, hear a powerful and smart conversation with NYU Grossman School of Medicine bioethicist Dr. Arthur Caplan, who is the absolute expert on this subject. A deeply thought-provoking episode on autonomy, suffering, and the boundaries of compassion.